Education
About Us
Working with TipRanks
Follow Us
Mochida Pharmaceutical Co., Ltd. (DE:MFY)
:MFY
Total Valuation
Mochida Pharmaceutical Co., Ltd. has a market cap or net worth of €598.78M. The enterprise value is €181.97B.
Market Cap€598.78M
Enterprise Value€181.97B
Share Statistics
Mochida Pharmaceutical Co., Ltd. has 36,390,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,390,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Mochida Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 4.24%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)4.24%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee69.09M
Profits Per Employee3.74M
Employee Count1,522
Asset Turnover0.66
Inventory Turnover1.54
Valuation Ratios
The current PE Ratio of Mochida Pharmaceutical Co., Ltd. is 19.83. Mochida Pharmaceutical Co., Ltd.’s PEG ratio is -0.53.
PE Ratio19.83
PS Ratio0.00
PB Ratio0.98
Price to Fair Value0.86
Price to FCF24.19
Price to Operating Cash Flow17.01
PEG Ratio-0.53
Income Statement
In the last 12 months, Mochida Pharmaceutical Co., Ltd. had revenue of 105.16B and earned 5.68B in profits. Earnings per share was 160.36.
Revenue105.16B
Gross Profit53.79B
Operating Income8.13B
Pretax Income8.05B
Net Income5.68B
EBITDA11.00B
Earnings Per Share (EPS)160.36
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Mochida Pharmaceutical Co., Ltd. pays an annual dividend of €0.242, resulting in a dividend yield of 2.85%
Dividend Per Share€0.242
Dividend Yield2.85%
Payout Ratio49.89%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change0.64%
50-Day Moving Average17.98
200-Day Moving Average19.53
Relative Strength Index (RSI)37.48
Average Volume (3m)0.00
Important Dates
Mochida Pharmaceutical Co., Ltd. upcoming earnings date is Aug 1, 2025, TBA Not Confirmed.
Last Earnings DateMay 12, 2025
Next Earnings DateAug 1, 2025
Ex-Dividend DateMar 28, 2025
Financial Position
Mochida Pharmaceutical Co., Ltd. as a current ratio of 4.81, with Debt / Equity ratio of 0.15%
Current Ratio4.81
Quick Ratio3.47
Debt to Market Cap0.00
Net Debt to EBITDA-4.11
Interest Coverage Ratio2.71K
Taxes
In the past 12 months, Mochida Pharmaceutical Co., Ltd. has paid 2.37B in taxes.
Income Tax2.37B
Effective Tax Rate0.29
Enterprise Valuation
Mochida Pharmaceutical Co., Ltd. EV to EBITDA ratio is 6.15, with an EV/FCF ratio of 9.39.
EV to Sales0.64
EV to EBITDA6.15
EV to Free Cash Flow9.39
EV to Operating Cash Flow7.22
Balance Sheet
Mochida Pharmaceutical Co., Ltd. has €53.58B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of -€53.58B billion.
Cash & Marketable Securities€53.58B
Total Debt¥0.00
Net Cash-€53.58B
Net Cash Per Share-€1.47K
Tangible Book Value Per Share€3.69K
Margins
Gross margin is 53.37%, with operating margin of 7.73%, and net profit margin of 5.41%.
Gross Margin53.37%
Operating Margin7.73%
Pretax Margin7.66%
Net Profit Margin5.41%
EBITDA Margin10.46%
EBIT Margin7.66%
Analyst Forecast
The average price target for Mochida Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―